Erstlinienbehandlung mit Cisplatin/Pemetrexed/Bevacizumab beim Pleuramesotheliom: Ergebnisse einer Phase-III-Studie = First-line treatment with cisplatin/pemetrexed/bevacizumab for pleural mesothelioma : results of a phase III study
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Deutsch |
| Veröffentlicht: |
7. Juni 2016
|
| In: |
Der Onkologe
Year: 2016, Jahrgang: 22, Heft: 8, Pages: 598-599 |
| ISSN: | 1433-0415 |
| DOI: | 10.1007/s00761-016-0066-9 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/s00761-016-0066-9 Verlag, Volltext: https://doi.org/10.1007/s00761-016-0066-9 |
| Verfasserangaben: | Helge G. Bischoff |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1584812389 | ||
| 003 | DE-627 | ||
| 005 | 20220815073433.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181205s2016 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00761-016-0066-9 |2 doi | |
| 035 | |a (DE-627)1584812389 | ||
| 035 | |a (DE-576)514812389 | ||
| 035 | |a (DE-599)BSZ514812389 | ||
| 035 | |a (OCoLC)1341024912 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a ger | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Bischoff, Helge |d 1958- |e VerfasserIn |0 (DE-588)111184576 |0 (DE-627)389658286 |0 (DE-576)167287249 |4 aut | |
| 245 | 1 | 0 | |a Erstlinienbehandlung mit Cisplatin/Pemetrexed/Bevacizumab beim Pleuramesotheliom |b Ergebnisse einer Phase-III-Studie = First-line treatment with cisplatin/pemetrexed/bevacizumab for pleural mesothelioma : results of a phase III study |c Helge G. Bischoff |
| 246 | 3 | 1 | |a First-line treatment with cisplatin/pemetrexed/bevacizumab for pleural mesothelioma |b results of a phase III study |
| 264 | 1 | |c 7. Juni 2016 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 05.12.2018 | ||
| 773 | 0 | 8 | |i Enthalten in |t Der Onkologe |d Berlin : Springer, 1996 |g 22(2016), 8, Seite 598-599 |h Online-Ressource |w (DE-627)254638546 |w (DE-600)1462966-5 |w (DE-576)074531522 |x 1433-0415 |7 nnas |a Erstlinienbehandlung mit Cisplatin/Pemetrexed/Bevacizumab beim Pleuramesotheliom Ergebnisse einer Phase-III-Studie = First-line treatment with cisplatin/pemetrexed/bevacizumab for pleural mesothelioma : results of a phase III study |
| 773 | 1 | 8 | |g volume:22 |g year:2016 |g number:8 |g pages:598-599 |g extent:2 |a Erstlinienbehandlung mit Cisplatin/Pemetrexed/Bevacizumab beim Pleuramesotheliom Ergebnisse einer Phase-III-Studie = First-line treatment with cisplatin/pemetrexed/bevacizumab for pleural mesothelioma : results of a phase III study |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00761-016-0066-9 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00761-016-0066-9 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181205 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 111184576 |a Bischoff, Helge |m 111184576:Bischoff, Helge |d 910000 |d 950000 |d 950900 |e 910000PB111184576 |e 950000PB111184576 |e 950900PB111184576 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN1584812389 |e 3036638539 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Helge G. Bischoff"]},"id":{"eki":["1584812389"],"doi":["10.1007/s00761-016-0066-9"]},"recId":"1584812389","physDesc":[{"extent":"2 S."}],"titleTranslated":[{"translated":"First-line treatment with cisplatin/pemetrexed/bevacizumab for pleural mesothelioma"}],"origin":[{"dateIssuedDisp":"7. Juni 2016","dateIssuedKey":"2016"}],"person":[{"display":"Bischoff, Helge","role":"aut","given":"Helge","family":"Bischoff"}],"relHost":[{"pubHistory":["Nachgewiesen 2.1996,3 - Volume 28, issue 4, (April 2022)"],"origin":[{"dateIssuedDisp":"1996-2022","dateIssuedKey":"1996","publisherPlace":"Berlin ; Heidelberg ; New York","publisher":"Springer"}],"note":["Gesehen am 18.02.04","Ungezählte Beil.: Supplement"],"language":["ger"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title":"Der Onkologe","title_sort":"Onkologe","subtitle":"Organ der Deutschen Krebsgesellschaft e.V."}],"part":{"volume":"22","year":"2016","text":"22(2016), 8, Seite 598-599","extent":"2","issue":"8","pages":"598-599"},"id":{"eki":["254638546"],"issn":["1433-0415"],"zdb":["1462966-5"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"254638546","disp":"Erstlinienbehandlung mit Cisplatin/Pemetrexed/Bevacizumab beim Pleuramesotheliom Ergebnisse einer Phase-III-Studie = First-line treatment with cisplatin/pemetrexed/bevacizumab for pleural mesothelioma : results of a phase III studyDer Onkologe"}],"title":[{"title":"Erstlinienbehandlung mit Cisplatin/Pemetrexed/Bevacizumab beim Pleuramesotheliom","title_sort":"Erstlinienbehandlung mit Cisplatin/Pemetrexed/Bevacizumab beim Pleuramesotheliom","subtitle":"Ergebnisse einer Phase-III-Studie = First-line treatment with cisplatin/pemetrexed/bevacizumab for pleural mesothelioma : results of a phase III study"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["ger"],"note":["Gesehen am 05.12.2018"]} | ||
| SRT | |a BISCHOFFHEERSTLINIEN7201 | ||